Point Partial for Hand Amputation

N/A

Waitlist Available

Research Sponsored by Point Designs

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up ~day 60: with prosthesis, 60 days post-fitting

Awards & highlights

No Placebo-Only Group

Summary

This trial will test if the Point Partial prosthetic device helps people with partial finger amputations function better and feel better in everyday life. It aims to show that using this device outside the lab can provide real-world benefits.

Eligible Conditions

Hand Amputation

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ ~day 60: with prosthesis, 60 days post-fitting

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~~day 60: with prosthesis, 60 days post-fitting

This trial's timeline: 3 weeks for screening, Varies for treatment, and ~day 60: with prosthesis, 60 days post-fitting for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Upper Extremity

Disability of the Arm, Shoulder and Hand (DASH)

EuroQol-5 Dimension (EQ-5D-5L)

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: ProsthesisExperimental Treatment1 Intervention

Outcome measurements will be performed after the subject has been fit with a prosthesis at 3 different points in time: immediately post-fitting, \~30 days post-fitting, and \~60 days post-fitting

Group II: No ProsthesisActive Control1 Intervention

Baseline outcome measurements will be performed without a prosthesis

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Point Partial

2021

N/A

~20

Do I qualify?Apply below to find out